Recalibration: Exploring the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Self-Concept for Adults with Cystic Fibrosis

Key Points

• To explore how elexacaftor/tezacaftor/ivacaftor affects self-concept in adults with cystic fibrosis.
• Examined self-concept approach in cystic fibrosis management.
• Included adults with cystic fibrosis receiving treatment.
• Evaluated changes in self-perception pre and post-intervention.
• Enhanced self-concept reported among participants after treatment.
• Positive shifts in self-image linked to the medication's impact.
• Improvements noted in overall quality of life measures.